# FDA 483 - Toshko J. Lissitchkov, MD, PhD - April 19, 2019

Source: https://www.globalkeysolutions.net/records/483/toshko-j-lissitchkov-md-phd/e6dfdaaf-d2d8-4197-8f10-74f80eef870f

> FDA 483 for Toshko J. Lissitchkov, MD, PhD on April 19, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Toshko J. Lissitchkov, MD, PhD
- Inspection Date: 2019-04-19
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
- Summary: An FDA inspection of Toshko J. Lissitchkov, M.D., PhD, a clinical investigator in Sofia, Bulgaria, identified one observation. The firm failed to conduct an investigation in accordance with its investigational plan. This involved not performing a required assessment during a study completion visit.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/zerita-white/82b19f0c-bd17-4a44-8523-8986f38851a8)

Company: https://www.globalkeysolutions.net/companies/toshko-j-lissitchkov-md-phd/b72356e5-7f2e-47b0-8094-5e551537e02e

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd